APOB and coronary artery disorder: A recent genome-wide association study (GWAS) using UK Biobank (UKBB) data and MR analysis [13] reported that among atherogenic lipid-related traits (apolipoprotein B [Apo-B], low-density lipoprotein cholesterol [LDL-C], and triglyceride [TG]), Apo-B accounted for the causal effect on CAD risk, independently of LDL-C and TGs.